Stanley H. Yeung

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Increased interleukin-6 is associated with higher risk of heart failure in people with type 2 diabetes.

Increased interleukin-6 is associated with higher risk of heart failure in people with type 2 diabetes.

Journal: ESC heart failure

Published: July 27, 2023

Short-Term Effects of Potassium Chloride Supplementation on Fibroblast Growth Factor 23 and Phosphate in CKD.

Short-Term Effects of Potassium Chloride Supplementation on Fibroblast Growth Factor 23 and Phosphate in CKD.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: November 10, 2022

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study.

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study.

Journal: Journal of the American Heart Association

Published: July 25, 2022

Low Urinary Potassium Excretion Is Associated with Higher Risk of All-Cause Mortality in Patients with Type 2 Diabetes: Results of the Dutch Diabetes and Lifestyle Cohort Twente (DIALECT).

Low Urinary Potassium Excretion Is Associated with Higher Risk of All-Cause Mortality in Patients with Type 2 Diabetes: Results of the Dutch Diabetes and Lifestyle Cohort Twente (DIALECT).

Journal: The Journal of nutrition

Published: May 05, 2022

Modified urine typing to enhance clinical management in kidney transplant patients with unknown donor human leukocyte antigen typing: abridged secondary publication.

Modified urine typing to enhance clinical management in kidney transplant patients with unknown donor human leukocyte antigen typing: abridged secondary publication.

Journal: Hong Kong medical journal = Xianggang yi xue za zhi

Published: March 09, 2022

Effects of Short-Term Potassium Chloride Supplementation in Patients with CKD.

Effects of Short-Term Potassium Chloride Supplementation in Patients with CKD.

Journal: Journal of the American Society of Nephrology : JASN

Published: February 07, 2022

Urinary Potassium Excretion, Fibroblast Growth Factor 23, and Incident Hypertension in the General Population-Based PREVEND Cohort.

Urinary Potassium Excretion, Fibroblast Growth Factor 23, and Incident Hypertension in the General Population-Based PREVEND Cohort.

Journal: Nutrients

Published: December 02, 2021

Urinary potassium excretion and mortality risk in community-dwelling individuals with and without obesity.

Urinary potassium excretion and mortality risk in community-dwelling individuals with and without obesity.

Journal: The American journal of clinical nutrition

Published: October 27, 2021

Phosphate and fibroblast growth factor 23 in diabetes.

Phosphate and fibroblast growth factor 23 in diabetes.

Journal: Clinical science (London, England : 1979)

Published: April 16, 2021

Net Endogenous Acid Excretion and Kidney Allograft Outcomes.

Net Endogenous Acid Excretion and Kidney Allograft Outcomes.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: January 18, 2021

Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony.

Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony.

Journal: Current diabetes reports

Published: August 29, 2020

Effects of Potassium or Sodium Supplementation on Mineral Homeostasis: A Controlled Dietary Intervention Study.

Effects of Potassium or Sodium Supplementation on Mineral Homeostasis: A Controlled Dietary Intervention Study.

Journal: The Journal of clinical endocrinology and metabolism

Published: April 02, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026